New study shows Japan most expensive for investing in clinical trials, followed by Australia

A new international report on the global competitiveness of 14 countries has ranked Japan competitive as the most expensive market for clinical trial investment, closely followed by Australia.

The 2012 KPMG Competitive Alternatives report shows that the Japanese cities Osaka and Tokyo ranked 112 and 113, respectively. Australia’s Brisbane ranks 110th and Sydney ranks 111th out of 113 in the list of most expensive cities – more expensive than every city except Melbourne at 108th and Adelaide 103rd.

By country overall, Italy and Germany virtually tied at 107.0 and 107.5, with the USA coming in next at 100. Brazil was 99.5 and the UK was 94.6. Ranking well were India at 46.1, China at 52.7 and Russia at 62.8.